176 related articles for article (PubMed ID: 9315332)
1. The in vivo anabolic actions of prostaglandins in bone.
Jee WS; Ma YF
Bone; 1997 Oct; 21(4):297-304. PubMed ID: 9315332
[No Abstract] [Full Text] [Related]
2. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC
J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
[TBL] [Abstract][Full Text] [Related]
3. Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain.
Yao W; Jee WS; Zhou H; Lu J; Cui L; Setterberg R; Liang T; Ma Y
Bone; 1999 Dec; 25(6):697-702. PubMed ID: 10593415
[TBL] [Abstract][Full Text] [Related]
4. Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2.
Mori S; Jee WS; Li XJ
Calcif Tissue Int; 1992 Jan; 50(1):80-7. PubMed ID: 1739875
[TBL] [Abstract][Full Text] [Related]
5. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
Ma YF; Pan Z; Jee WS; Lin CH; Liang HH; Chen H; Pun S; Li XJ
J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
[TBL] [Abstract][Full Text] [Related]
6. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
7. Long-term anabolic effects of prostaglandin-E2 on tibial diaphyseal bone in male rats.
Jee WS; Ke HZ; Li XJ
Bone Miner; 1991 Oct; 15(1):33-55. PubMed ID: 1747567
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates: pharmacology and effects on the growing skeleton.
Papapoulos SE
Acta Univ Carol Med (Praha); 1994; 40(1-4):29-32. PubMed ID: 9355668
[No Abstract] [Full Text] [Related]
9. Cancellous bone of aged rats maintains its capacity to respond vigorously to the anabolic effects of prostaglandin E2 by modeling-dependent bone gain.
Cui L; Ma YF; Yao W; Zhou H; Setterberg RB; Liang TC; Jee WS
J Bone Miner Metab; 2001; 19(1):29-37. PubMed ID: 11156470
[TBL] [Abstract][Full Text] [Related]
10. The effects of PTH (1-34) on bone structure and strength in ovariectomized monkeys.
Turner CH; Burr DB; Hock JM; Brommage R; Sato M
Adv Exp Med Biol; 2001; 496():165-79. PubMed ID: 11783618
[No Abstract] [Full Text] [Related]
11. Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats.
Jee WS; Ke HZ; Li XJ
Bone Miner; 1992 Apr; 17(1):31-47. PubMed ID: 1581704
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo effects of ipriflavone on bone formation and bone biomechanics.
Civitelli R
Calcif Tissue Int; 1997; 61 Suppl 1():S12-4. PubMed ID: 9263610
[TBL] [Abstract][Full Text] [Related]
13. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
[TBL] [Abstract][Full Text] [Related]
14. Receptor activator of NF-[kappa]B ligand arrests bone growth and promotes cortical bone resorption in growing rats.
McHugh NA; Vercesi HM; Egan RW; Hey JA
J Appl Physiol (1985); 2003 Aug; 95(2):672-6. PubMed ID: 12692138
[TBL] [Abstract][Full Text] [Related]
15. The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system?
Delmas PD; Vergnaud P; Arlot ME; Pastoureau P; Meunier PJ; Nilssen MH
Bone; 1995 Jun; 16(6):603-10. PubMed ID: 7669436
[TBL] [Abstract][Full Text] [Related]
16. Enhanced trabecular-bone calcium deposition in female rats with a high physiological dose of prolactin diminishes after ovariectomy.
Puntheeranurak S; Charoenphandhu N; Krishnamra N
Can J Physiol Pharmacol; 2006 Oct; 84(10):993-1002. PubMed ID: 17218965
[TBL] [Abstract][Full Text] [Related]
17. Effect of denosumab on the growing skeleton in osteogenesis imperfecta.
Hoyer-Kuhn H; Semler O; Schoenau E
J Clin Endocrinol Metab; 2014 Nov; 99(11):3954-5. PubMed ID: 25148238
[No Abstract] [Full Text] [Related]
18. Clinical effects of bisphosphonates in involutional osteoporosis.
Ott SM
J Bone Miner Res; 1993 Dec; 8 Suppl 2():S597-606. PubMed ID: 8122531
[TBL] [Abstract][Full Text] [Related]
19. Quantification of skeletal growth, modeling, and remodeling by in vivo micro computed tomography.
Altman AR; Tseng WJ; de Bakker CMJ; Chandra A; Lan S; Huh BK; Luo S; Leonard MB; Qin L; Liu XS
Bone; 2015 Dec; 81():370-379. PubMed ID: 26254742
[TBL] [Abstract][Full Text] [Related]
20. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats.
Shen V; Birchman R; Liang XG; Wu DD; Dempster DW; Lindsay R
J Bone Miner Res; 1998 May; 13(5):883-90. PubMed ID: 9610753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
